GOLDSMITH MARK A sold RVMD
December 16, 2025 · Form 4 insider transaction
GOLDSMITH MARK A sold 15,394 shares of Revolution Medicines, Inc. at $76.82 per share, a transaction worth $1.18M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,394
Price
$76.82
Total value
$1.18M
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after232,469
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; Includes 168,763 restricted stock units.